The forecasting errors, along with the visual aids, suggest that the models, in general, have very good prediction accuracy, and the approach is suitable for predicting VA outcomes during anti-VEGF treatment for AMD patients. This evidence concerns the gene VEGFA and age-related macular degeneration.